FDA Inspection 933754 — BBT Biotech Gmbh
The FDA completed an inspection of BBT Biotech Gmbh on May 7, 2015 in Baesweiler. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 7, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Baesweiler (Germany)